Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367730 · ClinicalTrials.gov registry record
Assessment of Bone Micro-Architecture Using HR-pQCT
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 80
- Enrollment target
NCT01367730: Completed study, sponsored by University of California, San Francisco.
NCT01367730 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01367730 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
In the context of male osteoporosis, we hypothesize that regional changes in trabecular bone, as well as changes in cortical porosity will play a major role, and thus also affect bone strength. In developing therapeutics the response of individual compartments, regional variations post-therapy will have considerable impact on selecting the therapies as well as monitoring response to therapy. This study, a precursor to other therapeutic trials, will lay the ground-work for the future.
Primary Outcome
Trabecular bone micro-architecture as measured by trabecular number, trabecular BMD, and trabecular bone volume fraction (BV/TV). Cortical bone micro-architecture will be assessed by measuring cortical density \& thickness and porosity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-06 |
What the finished NCT01367730 record still lists
NCT01367730 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01367730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01367730 about?
NCT01367730 is a clinical study titled "Assessment of Bone Micro-Architecture Using HR-pQCT". In the context of male osteoporosis, we hypothesize that regional changes in trabecular bone, as well as changes in cortical porosity will play a major role, and thus also affect bone strength. In developing therapeutics the response of individual compartments, regional variations post-therapy will ...
What is the current status of trial NCT01367730?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2012-04. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01367730?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia